Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live4/30/2026, 2:41:24 PM
sha256:d746eContent snapshot
{ "nct_id": "NCT05021536", "phase": "phase_3", "status": "completed", "domain": "als", "indication": "ALS (no genetic stratification)", "intervention": "AMX0035 (sodium phenylbutyrate + taurursodiol)", "sponsor": "Amylyx", "n_enrolled": 664, "primary_endpoint": "ALSFRS-R change at 48 weeks", "summary": "PHOENIX failed primary; Relyvrio voluntarily withdrawn April 2024. Triggered post-hoc reflection on Phase 2 effect-size inflation.", "metadata": {} }